Literature DB >> 1467788

The c-met/HGF receptor in human tumours.

S Giordano1, M F di Renzo, M Olivero, A Mondino, Z Zhen, E Medico, P M Comoglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1467788     DOI： 10.1097/00008469-199210003-00007

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN： 0959-8278            Impact factor:   2.497


× No keyword cloud information.
  10 in total

1.  Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculations.

Authors:  Zhe Yu; Yu-chi Ma; Jing Ai; Dan-qi Chen; Dong-mei Zhao; Xin Wang; Yue-lei Chen; Mei-yu Geng; Bing Xiong; Mao-sheng Cheng; Jing-Kang Shen
Journal:  Acta Pharmacol Sin       Date:  2013-09-23       Impact factor: 6.150

Review 2.  Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

3.  Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.

Authors:  A Danilkovitch-Miagkova; A Miagkov; A Skeel; N Nakaigawa; B Zbar; E J Leonard
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

4.  Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.

Authors:  Laurel Stevens; Lindy McClelland; Alex Fricke; Magali Williamson; Ihsin Kuo; Glynis Scott
Journal:  J Invest Dermatol       Date:  2010-02-18       Impact factor: 8.551

5.  Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.

Authors:  Nancy E Castro; Carol A Lange
Journal:  Breast Cancer Res       Date:  2010-08-05       Impact factor: 6.466

6.  Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice.

Authors:  R Wang; L D Ferrell; S Faouzi; J J Maher; J M Bishop
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

7.  Human colorectal cancer-derived carcinoma associated fibroblasts promote CD44-mediated adhesion of colorectal cancer cells to endothelial cells by secretion of HGF.

Authors:  Rongsheng Zhang; Fan Qi; Shengli Shao; Geng Li; Yongdong Feng
Journal:  Cancer Cell Int       Date:  2019-07-24       Impact factor: 5.722

8.  Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis.

Authors:  Jian-Feng Yao; Xiao-Jun Li; Li-Kun Yan; Sai He; Jian-Bao Zheng; Xiao-Rong Wang; Pei-Hua Zhou; Li Zhang; Guang-Bing Wei; Xue-Jun Sun
Journal:  J Biochem Mol Toxicol       Date:  2019-03-21       Impact factor: 3.642

9.  TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors.

Authors:  Marco Gymnopoulos; Oscar Betancourt; Vincent Blot; Ryo Fujita; Diana Galvan; Vincent Lieuw; Sophie Nguyen; Jeanette Snedden; Christine Stewart; Jose Villicana; Jon Wojciak; Eley Wong; Raul Pardo; Neki Patel; Francois D'Hooge; Balakumar Vijayakrishnan; Conor Barry; John A Hartley; Philip W Howard; Roland Newman; Julia Coronella
Journal:  Mol Oncol       Date:  2019-12-03       Impact factor: 6.603

10.  Verticillin A inhibits colon cancer cell migration and invasion by targeting c-Met.

Authors:  Qian-Qian Liu; Xue-Li Zeng; Yue-Lin Guan; Jing-Xin Lu; Kai Tu; Fei-Yan Liu
Journal:  J Zhejiang Univ Sci B       Date:  2020-10       Impact factor: 3.066
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.